Investigating the impact of oncology phase II trial design parameters on their ability to successfully screen new treatments

Elbeltagi, Nada ORCID: 0000-0003-1084-7099 (2022) Investigating the impact of oncology phase II trial design parameters on their ability to successfully screen new treatments. PhD thesis, University of Leeds.

Abstract

Metadata

Supervisors: Brown, Sarah and Brown, Julia and Stallard, Nigel and Collinson, Fiona
Keywords: Phase II trials, design, endpoints, sample size, randomised, single-arm, two-stage, single stage, phase III success
Awarding institution: University of Leeds
Academic Units: The University of Leeds > Faculty of Medicine and Health (Leeds)
The University of Leeds > Faculty of Medicine and Health (Leeds) > School of Medicine (Leeds)
Academic unit: Leeds Institute of Clinical Trials Research
Identification Number/EthosID: uk.bl.ethos.868523
Depositing User: Miss Nada Elbeltagi
Date Deposited: 14 Dec 2022 15:12
Last Modified: 11 Jan 2023 15:03

Download

Export

Statistics


You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.